Literature DB >> 31522948

[The impact of obesity on respiratory function].

P Bokov1, C Delclaux2.   

Abstract

The respiratory impact of obesity can be both symptomatic (resting and exertional breathlessness) and functional (pulmonary function at rest and on exercise). The prevalence of breathlessness is increased in adult obese individuals, ∼50% at rest and ∼75% on exertion (mMRC score>0). Pulmonary function abnormalities in obese adults include reduced functional residual capacity (FRC) and expiratory residual volume (ERV), and less frequently reduced total lung capacity (a restrictive defect, with TLC below the 5th percentile of predicted is present in around 15% in severe obese adults), with normal residual volume (RV). Airflows are barely affected by obesity, but bronchial hyperresponsiveness (BHR) is very prevalent, which may be due to the loss of bronchoprotective effect of deep inspiration in obesity (mechanical pathophysiology of BHR). In children, the modifications of lung volumes seen are quite different: TLC is normal while FRC and RV are reduced, explaining the increase in FVC. FEV1/FVC is therefore reduced by obesity, without true airflow obstruction (dysanaptic growth). Resting oxygen consumption (V'O2) is increased due to obesity and normally increases with exercise. Maximum V'O2 is normal or weakly reduced in obese patients; on the other hand, the increase in respiratory load increases the oxygen cost of ventilation, which tends to be rapid, both at rest and during exertion. Finally, it should be noted that there is only limited statistical correlation between exercise dyspnoea and respiratory function abnormalities in obesity.
Copyright © 2019 SPLF. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Bronchial hyperresponsiveness; Compliance; Dyspnoea; Dyspnée; Exercise test; Hyperréactivité bronchique; Static volumes; Test à l’exercice; Volumes statiques

Mesh:

Year:  2019        PMID: 31522948     DOI: 10.1016/j.rmr.2019.07.009

Source DB:  PubMed          Journal:  Rev Mal Respir        ISSN: 0761-8425            Impact factor:   0.622


  3 in total

1.  Risk Factors for COVID-19: Diabetes, Hypertension, and Obesity.

Authors:  Silvio Buscemi; Davide Corleo; Cristiana Randazzo
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Assessment of Cardio-Respiratory Function in Overweight and Obese Children Wearing Face Masks during the COVID-19 Pandemic.

Authors:  Riccardo Lubrano; Silvia Bloise; Mariateresa Sanseviero; Alessia Marcellino; Claudia Proietti Ciolli; Enrica De Luca; Alessia Testa; Anna Dilillo; Saverio Mallardo; Sara Isoldi; Vanessa Martucci; Emanuela Del Giudice; Rita Leone; Donatella Iorfida; Flavia Ventriglia
Journal:  Children (Basel)       Date:  2022-07-14

Review 3.  Evaluating Possible Mechanisms Linking Obesity to COVID-19: a Narrative Review.

Authors:  Maryam Vasheghani; Zahra Hessami; Mahsa Rekabi; Atefeh Abedini; Akram Qanavati
Journal:  Obes Surg       Date:  2022-02-03       Impact factor: 3.479

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.